Stability Studies SOP

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability studies for vaccines in accordance with World Health Organization (WHO) guidelines. This SOP ensures that stability data supports the quality, safety, and efficacy of vaccines throughout their shelf life.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability testing for gene therapy products in accordance with US FDA requirements. This SOP ensures that stability data supports the quality, safety, and efficacy of gene therapy products throughout their shelf life.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability testing for cell therapy products in accordance with the ICH Q5A guidelines. This SOP ensures that stability data supports the quality, safety, and efficacy of cell therapy products throughout their shelf life.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability testing of radiopharmaceuticals in accordance with the ICH guidelines. This SOP ensures that stability data supports the quality, safety, and efficacy of radiopharmaceutical products throughout their shelf life.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability studies for drug products in accordance with the Central Drugs Standard Control Organization (CDSCO) of India. This SOP ensures that stability data supports the quality, safety, and efficacy of drug products throughout their shelf life.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability testing for drugs with novel delivery systems in accordance with US FDA requirements. This SOP ensures that stability data supports the quality, safety, and efficacy of these drugs throughout their shelf life.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for conducting stability testing for Advanced Therapy Medicinal Products (ATMPs) in accordance with European Medicines Agency (EMA) guidelines. This SOP ensures that stability data supports the quality, safety, and efficacy of ATMPs throughout their shelf life.
Click to read the full article.

The purpose of this Standard Operating Procedure (SOP) is to provide guidelines for designing stability studies for drug products with extended shelf life in accordance with relevant regulatory guidelines. This SOP ensures that stability data supports the quality, safety, and efficacy of drug products over their extended shelf life.
Click to read the full article.

The purpose of this SOP is to establish a systematic approach to ensure compliance with global stability testing requirements as set by major regulatory authorities such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and World Health Organization (WHO). This SOP provides guidelines for maintaining and demonstrating the stability of drug products throughout their shelf life to meet the varying requirements of different regulatory bodies.
Click to read the full article.

The purpose of this SOP is to define the procedures for conducting stability studies on fixed-dose combination (FDC) products to comply with regulatory guidelines. This SOP ensures that stability data for FDC products is generated in accordance with applicable regulatory requirements, ensuring the quality, safety, and efficacy of the product throughout its shelf life.
Click to read the full article.